Matt Meyerson

Charles A. Dana Chair in Human Cancer Genetics, Dana-Farber Cancer Institute

Professor of Genetics and Medicine, Harvard Medical School

Director, Center for Cancer Genomics, Dana-Farber Cancer Institute

Dana Farber Cancer Institute

617-632-4377

Meyerson Lab

Publications

Allele-specific amplification in cancer revealed by SNP array analysis.

Authors: Authors: LaFramboise T, Weir BA, Zhao X, Beroukhim R, Li C, Harrington D, Sellers WR, Meyerson M.
PLoS Comput Biol 2005-11-01
View full abstract on Pubmed

The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis.

Authors: Authors: Yokoyama A, Somervaille TC, Smith KS, Rozenblatt-Rosen O, Meyerson M, Cleary ML.
Cell 2005-10-21
View full abstract on Pubmed

Menin regulates pancreatic islet growth by promoting histone methylation and expression of genes encoding p27Kip1 and p18INK4c.

Authors: Authors: Karnik SK, Hughes CM, Gu X, Rozenblatt-Rosen O, McLean GW, Xiong Y, Meyerson M, Kim SK.
Proc Natl Acad Sci U S A 2005-10-11
View full abstract on Pubmed

Epidermal growth factor-independent transformation of Ba/F3 cells with cancer-derived epidermal growth factor receptor mutants induces gefitinib-sensitive cell cycle progression.

Authors: Authors: Jiang J, Greulich H, Jänne PA, Sellers WR, Meyerson M, Griffin JD.
Cancer Res 2005-10-01
View full abstract on Pubmed

An alternative inhibitor overcomes resistance caused by a mutation of the epidermal growth factor receptor.

Authors: Authors: Kobayashi S, Ji H, Yuza Y, Meyerson M, Wong KK, Tenen DG, Halmos B.
Cancer Res 2005-08-15
View full abstract on Pubmed

Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma.

Authors: Authors: Garraway LA, Widlund HR, Rubin MA, Getz G, Berger AJ, Ramaswamy S, Beroukhim R, Milner DA, Granter SR, Du J, Lee C, Wagner SN, Li C, Golub TR, Rimm DL, Meyerson ML, Fisher DE, Sellers WR.
Nature 2005-07-07
View full abstract on Pubmed

Homozygous deletions and chromosome amplifications in human lung carcinomas revealed by single nucleotide polymorphism array analysis.

Authors: Authors: Zhao X, Weir BA, LaFramboise T, Lin M, Beroukhim R, Garraway L, Beheshti J, Lee JC, Naoki K, Richards WG, Sugarbaker D, Chen F, Rubin MA, Jänne PA, Girard L, Minna J, Christiani D, Li C, Sellers WR, Meyerson M.
Cancer Res 2005-07-01
View full abstract on Pubmed

Genomic and proteomic profiling of lung cancers: lung cancer classification in the age of targeted therapy.

Authors: Authors: Meyerson M, Carbone D.
J Clin Oncol 2005-05-10
View full abstract on Pubmed

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.

Authors: Authors: Levine RL, Wadleigh M, Cools J, Ebert BL, Wernig G, Huntly BJ, Boggon TJ, Wlodarska I, Clark JJ, Moore S, Adelsperger J, Koo S, Lee JC, Gabriel S, Mercher T, D'Andrea A, Fröhling S, Döhner K, Marynen P, Vandenberghe P, Mesa RA, Tefferi A, Griffin JD, Eck MJ, Sellers WR, Meyerson M, Golub TR, Lee SJ, Gilliland DG.
Cancer Cell 2005-04-01
View full abstract on Pubmed

EGFR gene mutations: a call for global x global views of cancer.

Authors: Authors: Sellers WR, Meyerson M.
J Natl Cancer Inst 2005-03-02
View full abstract on Pubmed